Skip to nav Skip to content

228 Stories Found

CAR T Clinical Trials for Multiple Myeloma Bring Promising New Treatments

Moffitt researchers are leaders in advancing the field of CAR T therapy and multiple myeloma clinical trials provide patients with exciting new...

The Future of CAR T for Gynecologic Cancers

Dr. Robert Wenham, a gynecologic oncologist and chair of the Gynecologic Oncology Program at Moffitt Cancer Center, answers five questions about the...

Promising CAR T-PSMA Clinical Trial in Patients with Metastatic Castration Resistant Prostate Cancer

Moffitt Cancer Center is opening a multi-center, open-label, Phase 1 clinical trial to identify the dose and regimen of CAR T-PSMA cells that can be...

Radioactive Iodine Treatment in Patients with Thyroid Cancer

It is currently more selective when it comes to which patients need to be treated with Radioactive Iodine Treatment. RAI is rarely used in patients...

Targeted Therapy in Thyroid Cancer

A new generation of systemic therapy for thyroid cancer targets specific gene mutations. Knowledge of the mutation helps clinicians to select the...

Endocrine Effects of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)

Covid-19 has changed our world and medicine since its identification in late 2019. The involvement of the endocrine system has not been well-defined,...

Nonsurgical Treatment of Thyroid Nodules

Over time, multiple techniques have been developed, including thermal ablation technologies, such as radiofrequency ablation.  Ethanol ablative...

Prostatic Artery Embolization: A Non-surgical Treatment for Chronic Prostatitis/Chronic Pelvic Pain from Radiation-Induced Prostatitis

PAE can alleviate lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH) in men with or without the diagnosis of prostate cancer

PARP Inhibitors Improve Survival Rate in Some Relapsed Ovarian Cancer Patients

Most women with advanced cases of ovarian cancer will mostly like see the disease return. The recurrence of cancer can be aggressive and potentially...

Preclinical Research Uses Oncolytic Adenovirus That Selectively Kills Cancer Cells While Revving Up The Immune System

Moffitt Cancer Center is working to develop a new cancer vaccine that could be used to treat several cancers by itself or in combination with other...

Artificial Intelligence Achieves Human-Level Performance on Several Natural Language Processing Pathology Benchmarks

New natural language processing transformer models could aid extraction of information from pathology reports and other electronic medical record...

TIL Immunotherapy Offers Promising Results in Metastatic Non-Small Cell Lung Cancer

A group of investigators at Moffitt Cancer Center initiated a trial to determine if non-small cell lung cancer patients could have response to TIL...

Geriatric Oncology Offers Prolonged Life Spans for Older Cancer Patients

Many older cancer patients feel limited in their pursuit of cancer treatments. For geriatric oncology patients, the pros and cons of anti-cancer...

August is National Immunization Awareness Month

The summer is a time for many families to get caught up on immunizations. The summer of 2020 may be more important than previous summers as COVID-19...

Exploring Application of TILs for Head and Neck Cancers

Testing the feasibility of expanding tumor-reactive TIL from head and neck tumors for the development of a clinical trial